Cogent Biosciences, Inc. (COGT) is an American biotechnology company focused on the development of innovative therapeutics for patients with oncological and genetic diseases. With a primary emphasis on targeted therapy and gene therapy, Cogent Biosciences aims to provide effective and personalized treatments. Their research and development efforts are centered on identifying new therapeutic targets and discovering innovative approaches to treatment. The shares of Cogent Biosciences, Inc. (COGT) may be suitable for investors seeking opportunities in the field of biotechnology and innovative therapeutics with potential in oncology and genetic diseases.